Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: Experience of the National NeuroAIDS Tissue Consortium

International Journal of Methods in Psychiatric Research

Volumn 15, Issue 3, 2006, Pages 131-138

  Morgello, Susan ^a,f   Holzer III, C E ^b   Ryan, E ^a   Young, C ^c   Naseer, M ^a   Castellon, S A ^d   Frol, A B ^e   Atkinson, J Hampton ^c   Gelman, B B ^b   Grant, I ^c   Singer, E J ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

^f MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

HIV; Interrater reliability; PRISM

Indexed keywords

ALCOHOL; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; OPIATE; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADULT; AGED; ARTICLE; CANNABIS ADDICTION; CLINICAL EVALUATION; CLINICAL RESEARCH; COHORT ANALYSIS; DRUG DEPENDENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERRATER RELIABILITY; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PREVALENCE; SUBSTANCE ABUSE; ADDICTION; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; CLINICAL TRIAL; COMORBIDITY; HEALTH SURVEY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; OBSERVER VARIATION; PATHOPHYSIOLOGY; PSYCHIATRIC DIAGNOSIS; PSYCHIATRY; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; VALIDATION STUDY;

ADULT; AGED; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; OBSERVER VARIATION; PSYCHIATRY; SUBSTANCE-RELATED DISORDERS;

EID: 33750726761     PISSN: 10498931     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpr.189     Document Type: Article

References (27)

1. Atkinson JH Jr, Grant I, Kennedy CJ, Richman DD, Spector SA, McCutchan JA. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Arch Gen Psychiatr 1988; 45(9): 859-64.
2. Berney A, Preisig M, Matthey ML, Ferrero F, Fenton BT. Diagnostic interview for genetic studies (DIGS): interrater and test-retest reliability of alcohol and drug diagnoses. Drug Alcohol Depend 2002; 65(2): 149-58.
3. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arc Gen Psychiatr 2001; 58(8): 721-8.
4. Chuang HT, Jason GW, Pajurkova EM, Gill MJ. Psychiatric morbidity in patients with HIV infection. Can J Psychiatr 1992; 37: 109-15.
5. Clarke DM, Smith GC, Herrman HE, McKenzie DP. Monash Interview for Liason Psychiatry (MILP). Development, reliability, and procedural validity. Psychosomatics 1998; 39(4): 318-28.
6. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37-46.
7. Hasin D, Trautman K, Miele G, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatr 1996; 153: 1195-201.
8. Helzer JE, Clayton PJ, Pambakian R, Reich T, Woodruff RA Jr, Reveley MA. Reliability of psychiatric diagnosis. II. The test/retest reliability of diagnostic classification. Arch Gen Psychiatr 1977; 34(2): 136-41.
9. Hesselbrock M, Easton C, Bucholz KK, Schuckit M, Hesselbrock V. A validity study of the SSAGA - a comparison with the SCAN. Addiction 1999; 94(9): 1361-70.
10. Holzer CE, Nguyen HT, Hirschfeld RM. Reliability of Diagnoses in Mood Disorders. Psychiatr Clin N Am 1996; 19(1): 73-84.
11. Keller MB, Klein DN, Hirschfeld RM, Kocsis JH, McCullough JP, Miller I, First MB, Holzer CP 3rd, Keitner GI, Marin DB, Shea T. Results of the DSM-IV mood disorders field trial. Am J Psychiatr 1995; 152(6): 843-9.
12. Lipsitz JD, Williams JB, Rabkin JG, Remien RH, Bradbury M, el Sadr W, Goetz R, Sorrell S, Gorman JM. Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatr 1994; 151: 1662-8.
13. Lyketsos CG, Hoover DR, Guccione M, Dew MA, Wesch JE, Bing EG, Treisman GJ. Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. Am J Psychiatr 1996; 153(11): 1430-7.
14. Maj M, Janssen R, Starace F, Zaudig M, Satz P, Sughondhabirom B, Luabeya M, Riedel R, Ndetei D, Calil H, Bing E, St Louis M, Sartorius N. WHO neuropsychiatric AIDS study, cross-sectional phase I: study design and psychiatric findings. Arch Gen Psychiatr 1994; 51: 39-49.
15. Martin CS, Pollock NK, Bukstein OG, Lynch KG. Inter-rater reliability of the SCID alcohol and substance-use disorders section among adolescents. Drug Alcohol Depend 2000; 59(2): 173-6.
16. Miele GM, Carpenter KM, Smith Cockerham M, Dietz Trautman K, Blaine J, Hasin DS. Concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS). Drug Alcohol Depend 2000; 59(1): 77-88.
17. Morgello S, Gelman BB, Kozlowski PB, Vinters HV, Masliah E, Cornford M, Cavert W, Marra C, Grant I, Singer EJ. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 2001; 27(4): 326-35.
18. Morrison MF, Petitto JM, Ten Have T, Gettes DR, Chiappini MS, Weber AL, Brinker-Spence P, Bauer RM, Douglas SD, Evans DL. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatr 2002; 159(5): 789-96.
19. Perkins D, Stern R, Golden R, Murphy C, Naftolowitz D, Evans D. Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. Am J Psychiatr 1994; 151: 233-6.
20. Rabkin JG, Ferrando SJ, Jacobsberg LB, Fishman B. Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study. Compr Psychiatr 1997a; 38(3): 146-54.
21. Rabkin JG, Goetz RR, Remien RH, Williams JB, Todak G, Gorman JM. Stability of mood despite HIV illness progression in a group of homosexual men. Am J Psychiatr 1997b; 154: 231-8.
22. Rabkin JG, Johnson J, Lin SH, Lipsitz JD, Remien RH, Williams JB, Gorman JM. Psychopathology in male and female HIV-positive and negative injecting drug use rs: longitudinal course over 3 years. AIDS 1997c; 11: 507-15.
23. Rosenberger PH, Bornstein RA, Nasrallah HA, Para MR Whitaker CC, Fass RJ, Rice RR Jr. Psychopathology in HIV infection: lifetime and current assessment. Compr Psychiarr 1993; 34(3): 150-8
24. Skre I, Onstad S, Torgersen S, Kringlen E. High interrater reliability for the Structured Clinical Interview for DSM-III-R Axis I (SCID-I). Acta Psychiatr Scand 1991; 84(2): 167-73.
25. Ventura J, Liberman RP, Green MF, Shaner A, Mintz J. Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatr Res 1998; 79(2): 163-73.
26. Williams J, Rabkin J, Remien R, Gorman J, Ehrhardt A. Multidisciplinary baseline assessment of homosexual men with and without HIV infection: Standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatr 1991; 48: 124-30.
27. Williams JB, Gibbon M, First MB, Spitzer RL, Davies M, Borus J, Howes MJ, Kane J, Pope HG Jr, Rounsaville B, Wittchen HU. The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatr 1992; 49(8): 630-6.